NCT06077851View on ClinicalTrials.gov

Continuous Monitoring of Vital Signs at Home (WARD HOME II)

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

October 3, 2023

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
Vital Sign MonitoringClinical DeteriorationHospital At Home
Interventions
DEVICE

Continuously monitoring

Included patients are monitored with WARD equipment the first days after discharge. Monitoring will last for a maximum of three days.

Trial Locations (1)

2400

RECRUITING

Bispebjerg Hospital, Copenhagen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Technical University of Denmark

OTHER

collaborator

Emergency Medical Services, Capital Region, Denmark

OTHER_GOV

lead

Bispebjerg Hospital

OTHER